丹麦国家队列:儿童及青年期癌症男性的父权率随时间变化趋势
该研究基于丹麦全国登记数据,纳入1978-2016年确诊的9353例儿童及青年期(<30岁)男性癌症患者,并按出生年份随机匹配150倍无癌男性。结果显示癌症幸存者成为父亲的风险显著低于无癌男性,但随时间推移,幸存者的父权率明显上升。
要点
- 儿童及青年期癌症男性父权率显著低于无癌男性,但随时间推移明显上升。
- 中枢神经系统癌症幸存者父权风险最低(HR 0.67,95%CI 0.57-0.79)。
- 实体瘤幸存者父权风险略高于无癌男性(HR 1.16,95%CI 1.12-1.20)。
核心结论
- 癌症幸存者父权率显著低于无癌男性,但随时间推移父权率明显上升。
研究设计与样本
- 全国登记队列研究,纳入1978-2016年确诊的9353例儿童及青年期男性癌症患者,并按出生年份随机匹配150倍无癌男性对照。
- 随访至首次生育、死亡、迁移或2017年12月31日,死亡作为竞争风险。
主要发现
- 中枢神经系统癌症幸存者父权风险最低(HR 0.67,95%CI 0.57-0.79),血液系统癌症次之(HR 0.90,95%CI 0.81-1.01),实体瘤最高(HR 1.16,95%CI 1.12-1.20)。
- 父权风险随时间上升:实体瘤从HR 0.78(95%CI 0.73-0.83)升至HR 1.08(95%CI 0.95-1.22),血液系统癌症从HR 0.64(95%CI 0.53-0.79)升至HR 0.97(95%CI 0.73-1.30),中枢神经系统癌症从HR 0.44(95%CI 0.34-0.57)升至HR 0.98(95%CI 0.49-1.95)。
- 20-29岁确诊的男性父权风险随时间上升(HR 0.80,95%CI 0.74-0.86至HR 1.08,95%CI 0.96-1.22)。
临床怎么用
- 应向男性癌症患者提供生育力保存选项及组建家庭机会的信息与教育。
- 近年更多有癌症史的男性成为父亲,反映生存率与生育力保存的改善。
局限性
- 基于登记数据,缺乏男性生育潜力、生育意愿及伴侣情况的信息。
- 缺乏生育力保存(如精子冷冻)及辅助生殖治疗的信息。
- 缺乏诊断及辅助生殖治疗的详细信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is the rate of fatherhood among men diagnosed with cancer in childhood and early adulthood different from men without cancer, and, if so, have the differences changed over time? SUMMARY ANSWER: Men diagnosed with cancer have had significantly reduced rates of fatherhood compared with undiagnosed men; however, the rates of fatherhood among the cancer survivors have increased markedly over time. WHAT IS KNOWN ALREADY: The number of children and young adolescents who survive cancer has steadily increased over recent decades, with a current 5-year survival rate of approximately 80%. Consequently, life circumstances after cancer have gained increasing importance, including the desire among survivors to have children and a family. ARTs to aid reproduction among cancer survivors have been developed, and fertility preservation is increasingly a topic being discussed before undergoing cancer treatment. But the potential for fertility preservation differs dependent on age at diagnosis and type of cancer. Earlier studies have shown a decreased fertility rate among survivors of child and adolescent cancer compared to those diagnosed in early adulthood. STUDY DESIGN, SIZE, DURATION: This study is a national, register-based cohort study. Men diagnosed with cancer in childhood and early adulthood (<30 years of age) were registered in the Danish Cancer Register in 1978-2016 (n = 9353). According to the time of diagnosis, each cancer-diagnosed man was randomly matched with 150 undiagnosed men from the background population within the same birth year. The men were followed until having their first child, death, migration or the end of the study (31 December 2017) in medical registers and socio-demographic population registers. PARTICIPANTS/MATERIALS, SETTING, METHODS: Fatherhood among the boys and young men diagnosed with cancer were compared with the age-matched comparison group in all statistical analyses. Cancer diagnoses were categorised as central nervous system (CNS) cancers, haematological cancers or solid cancers. Analyses were stratified by age at diagnosis (0-9, 10-19, 20-29 years) and time of diagnosis (1978-1989, 1990-1999, 2000-2009, 2010-2016). Death was incorporated as a competing risk in all analyses. MAIN RESULTS AND THE ROLE OF CHANCE: The study population consisted of 9353 boys and young men diagnosed with cancer between 1978 and 2016 and 1 386 493 men in the age-matched comparison group. Those surviving CNS cancer as young men had the lowest hazard ratio (HR) of fatherhood compared with the age-matched comparison group (HR 0.67, 95% CI 0.57-0.79), followed by survivors of haematological cancers (HR 0.90, 95% CI 0.81-1.01), while the highest chance of fatherhood was among survivors of solid cancers (HR 1.16, 95% CI 1.12-1.20) with a slightly increased HR compared with undiagnosed males. The HR of becoming a father increased over time. From the first decade to the last decade 30 years later, the HR of becoming a father increased for solid tumours (HR 0.78, 95% CI 0.73-0.83 to HR 1.08, 95% CI 0.95-1.22), haematological cancers (HR 0.64, 95% CI 0.53-0.79 to HR 0.97, 95% CI 0.73-1.30) and CNS cancers (HR 0.44, 95% CI 0.34-0.57 to HR 0.98, 95% CI 0.49-1.95) compared to the age-matched comparison group. Also, when compared with the age-matched comparison group, men diagnosed with cancer when aged 20-29 years were more likely became fathers over the time of the study (HR 0.80, 95% CI 0.74-0.86 to HR 1.08, 95% CI 0.96-1.22). LIMITATIONS, REASONS FOR CAUTION: The study was based on register data, and information was not available about the men's fertility potential, whether they had a desire to have children and whether it was possible for them to find a partner. Information about fertility preservation, e.g. sperm freezing, could also have provided additional insights. Furthermore, information about diagnosis and ART treatment would have been beneficial. WIDER IMPLICATIONS OF THE FINDINGS: Information and education of male patients diagnosed with cancer about fertility preservation options and their chances to create their own family is crucial. Reassuringly, time trends showed more men with a previous cancer diagnosis becoming fathers in recent years than in earlier years, reflecting that survival and fertility preservation have improved over time. STUDY FUNDING/COMPETING INTEREST(S): R.S. received a PhD grant from the Rosa Ebba Hansen Foundation and from the Health Foundation (J.nr. 15-B-0095). The funding for the establishment of the DANAC II Cohort was obtained from the Rosa Ebba Hansen Foundation. The authors have no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A.
引用
- Sylvest R, Vassard D, Schmidt L, et al. Parenthood among men diagnosed with cancer in childhood and early adulthood: trends over time in a Danish national cohort. Hum Reprod. 2021. PMID: 34166497. doi:10.1093/humrep/deab154
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。